论文部分内容阅读
目的:探讨血必净联合抗生素治疗老年重症社区获得性肺炎疗效。方法:选取该科2009年5月至2014年7月收治的老年重症社区获得性肺炎患者200例,随机分成观察组和对照组,两组均给予抗生素治疗,在此基础上,观察组加用血必净治疗,对照组单用抗生素治疗,对比分析两组临床治疗效果及不良反应发生情况。结果:观察组治疗总有效率显著高于对照组(P<0.05);两组患者均未出现明显的不良反应(P>0.05)。结论:血必净联合抗生素治疗老年重症社区获得性肺炎疗效满意,安全可靠,值得进一步研究和临床推广应用。
Objective: To investigate the effect of Xuebijing combined with antibiotics in the treatment of elderly patients with severe community-acquired pneumonia. Methods: 200 elderly patients with severe community-acquired pneumonia who were admitted to our department from May 2009 to July 2014 were randomly divided into observation group and control group. Both groups were given antibiotics. On this basis, Xuebijing treatment, the control group with antibiotic treatment, comparative analysis of two groups of clinical treatment and adverse reactions. Results: The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). No significant adverse reactions occurred in both groups (P> 0.05). Conclusion: The combination of Xuebijing and antibiotics in elderly patients with severe community-acquired pneumonia is satisfactory, safe and reliable, which is worth further study and clinical application.